1. Home
  2. FOSL vs ALEC Comparison

FOSL vs ALEC Comparison

Compare FOSL & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fossil Group Inc.

FOSL

Fossil Group Inc.

HOLD

Current Price

$3.88

Market Cap

135.9M

ML Signal

HOLD

Logo Alector Inc.

ALEC

Alector Inc.

HOLD

Current Price

$1.50

Market Cap

133.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FOSL
ALEC
Founded
1984
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Consumer Specialties
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
135.9M
133.2M
IPO Year
1993
2019

Fundamental Metrics

Financial Performance
Metric
FOSL
ALEC
Price
$3.88
$1.50
Analyst Decision
Strong Buy
Hold
Analyst Count
1
8
Target Price
$5.00
$3.50
AVG Volume (30 Days)
1.2M
1.7M
Earning Date
11-13-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,066,179,000.00
$69,048,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$160.66
P/E Ratio
N/A
N/A
Revenue Growth
N/A
12.26
52 Week Low
$0.86
$0.87
52 Week High
$4.40
$3.40

Technical Indicators

Market Signals
Indicator
FOSL
ALEC
Relative Strength Index (RSI) 71.42 54.67
Support Level $3.61 $1.18
Resistance Level $4.11 $1.39
Average True Range (ATR) 0.28 0.10
MACD 0.09 0.07
Stochastic Oscillator 86.44 91.11

Price Performance

Historical Comparison
FOSL
ALEC

About FOSL Fossil Group Inc.

Fossil Group Inc is a design, innovation and distribution company in consumer fashion accessories. The products include traditional watches, smartwatches, jewelry, handbags, small leather goods, belts and sunglasses. The reportable segments are comprised of 1) Americas segment includes sales in Canada, Latin America and the United States. 2) Europe segment includes sales in European countries, the Middle East and Africa. 3) Asia segment includes sales in Australia, China, India, Indonesia, Japan, Malaysia, New Zealand, Singapore, South Korea and Thailand. Each reportable operating segment includes sales to wholesale and distributor customers, and sales through Company-owned retail stores and e-commerce activities based on the location of the selling entity.

About ALEC Alector Inc.

Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.

Share on Social Networks: